Type
. A Study on the Incidence of the Ocular Complications of Leprosy in Resttlement Villages. Journal of the Korean Ophthalmological Society. 1989;30(6):981-986.
Type
. Significance of the Serum Levels of C - reactive Protein in Leprosy Patients with Planter Ulcer. Korean journal of dermatology. 1990;28(3):302-307.
Type
. Radiologic changes of ulcerated foot in leprosy. Journal of the Korean Radiological Society [Internet]. 1990;26(6):1236-1243. Available from: https://synapse.koreamed.org/Synapse/Data/PDFData/1016JKRS/jkrs-26-1236.pdf
Type
. Total igG and Ig anti PGL-I with duration of the therapy and reactions in multibaciller leprosy. Indonesian journal of clinical pathology and medical laboratory [Internet]. 2016;22(3):268–273. Available from: https://tinyurl.com/ybng8d9j
Type
. BCG and adverse events in the context of leprosy. Frontiers in immunology [Internet]. 2018;9:629. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2018.00629/pdf
Type
. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?. Diagnostic microbiology and infectious disease. 2018;.
Type
. Association of APOE polymorphisms with multibacillary leprosy. The British journal of dermatology. 2018;178(4):833-834.
Type
. Autoimmunity to Tropomyosin-Specific Peptides Induced by in Leprosy Patients: Identification of Mimicking Proteins. Frontiers in immunology [Internet]. 2018;9:642. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2018.00642/pdf
Type
. Detection of Mycobacterium leprae DNA Using Nested - PCR from Paraffin - embedded Tissue Samples. Korean journal of dermatology. 1994;32(3):462-468.
Type
. Evaluation of the Life Span in Leprosy Patients. Korean journal of dermatology. 1994;32(1):8-12.